Search results for "FAILURE"

showing 10 items of 1977 documents

Fluid therapy in non-septic, refractory acute decompensated heart failure patients – The cautious role of central venous pressure

2019

Purpose Fluid therapy in congestive acute decompensated heart failure (ADHF) patients might be inappropriate and worsening the prognosis. The aim of our study was to analyze the effect of fluid administration on mortality in non-septic, ADHF patients with reduced ejection fraction. Material and methods We analyzed 41 ADHF consecutive ‘cold-wet’ patients (mean age 69.3 ± 14.9 years, 27 men, LVEF 22.8 ± 11.1%, lactates 2.2 ± 1.6 mmol/L) without sepsis. At admission central venous pressure (CVP) was measured (17.6 ± 7.2 cm H2O), and ultrasound examination of inferior vena cava (IVC) was performed (IVC min. 18.6 ± 7.3 mm and IVC max. 24.6 ± 4.3 mm). Moreover, the groups were compared (survivors…

Malemedicine.medical_specialtyAcute decompensated heart failureKaplan-Meier EstimateInferior vena cavaStatistics NonparametricSepsisCentral venous pressure03 medical and health sciences0302 clinical medicineFluid therapyRefractoryFluid therapyInternal medicineSepsisMedicineHumans030212 general & internal medicineHospital MortalityAgedHeart FailureEjection fractionbusiness.industryCentral venous pressureAcute heart failureGeneral Medicinemedicine.diseasemedicine.veinQuartile030220 oncology & carcinogenesisCardiologyFemalebusinessAdvances in Medical Sciences
researchProduct

The Usefulness of Bioelectrical Impedance Analysis in Differentiating Dyspnea Due to Decompensated Heart Failure

2007

Acute dyspnea poses a diagnostic challenge for physicians, and the current methods in differentiating cardiac from non-cardiac causes have been limited to date. Recently, the brain natriuretic peptide (BNP) rapid test has been validated in the emergency room. Nevertheless, the early accumulation of fluid in the interstitial space in the body and in the lungs, which characterizes patients with ADHF, is well estimated by BIA. We investigate whether bioelectrical impedance analysis (BIA) can serve as a noninvasive diagnostic tool in the differential diagnosis of acute decompensated heart failure (ADHF) in the emergency department (ED).A total of 292 patients presenting with acute dyspnea to th…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.drug_classSensitivity and SpecificityDiagnosis DifferentialInternal medicineNatriuretic Peptide BrainElectric ImpedancemedicineNatriuretic peptideHospital dischargeHumansIntensive care medicineAgedHeart Failurebusiness.industryEmergency departmentMiddle Agedmedicine.diseaseBrain natriuretic peptideDyspneaROC CurveHeart failureCardiologyFemaleDifferential diagnosisCardiology and Cardiovascular MedicinebusinessBioelectrical impedance analysisAlgorithmsJournal of Cardiac Failure
researchProduct

The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?

2012

Glucocorticoid administration is not recommended in patients with heart failure because of its related sodium and fluid retention. However, previous experimental and clinical studies have demonstrated that glucocorticoids can also induce a diuretic effect and improve renal function in patients with acute decompensated heart failure (ADHF) with refractory diuretic resistance. We report the case of a 65-year-old man with a known diagnosis of aortic stenosis, systolic ventricular dysfunction, and chronic obstructive pulmonary disease who was admitted for ADHF. After 3 days, during which resistance to conventional therapy was observed, intravenous methylprednisolone (60 mg/d) was added to ongoi…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.medical_treatmentRenal functionMethylprednisoloneRefractoryInternal medicinemedicineHumansDiureticsGlucocorticoidsAgedHeart Failurebusiness.industryGeneral Medicinemedicine.diseaseBrain natriuretic peptideStenosisglucocorticoid. acute decompensated hert failureEndocrinologyHeart failureAcute DiseaseEmergency MedicineCardiologyDiureticbusinessGlucocorticoidmedicine.drug
researchProduct

Ventricular dysfunction and number of non compacted segments in non compaction: Non-independent predictors.

2010

Abstract Background Isolated ventricular noncompaction (IVNC) is characterized by multiple prominent trabeculations and deep intertrabecular recesses. Some reports prove that the chronic heart failure may occur in approximately half of the patients. In this report we investigate the correlation between the number of non compacted segments and entity of systolic dysfunction from the registry and subregistries of the SIEC. Method To identify the correlation between ventricular dysfunction and number of segments involved in non compaction we evaluated a consecutive series of 238 patients affected by non compaction, from the SIEC (Societa Italiana di Ecografia Cardiovascolare) registry. The ave…

Malemedicine.medical_specialtyAdolescentCardiomyopathyVentricular non compactionDiastoleCardiomyopathyProminent trabeculationsSeverity of Illness IndexNOVentricular Dysfunction LeftYoung AdultPredictive Value of TestsInternal medicinemedicineHumansRegistriesChildVentricular dysfunctionAgedVentricular non compaction; Cardiomyopathy; Ventricular dysfunction; Number of segments; Compact/spongy ratioAged 80 and overIsolated Noncompaction of the Ventricular Myocardiumbusiness.industryCompact/spongy ratioInfantMiddle Agedmedicine.diseaseNumero signPredictive factorSurgeryHeart failureChild PreschoolCardiologyNumber of segmentsFemaleMyocardial diseaseCardiology and Cardiovascular MedicinebusinessCardiomyopathy; Number of segments Compact/spongy ratio; Ventricular dysfunction; Ventricular non compactionHeart Failure Systolic
researchProduct

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

2015

Background Extended-release guanfacine hydrochloride (GXR), a selective α2A-adrenergic agonist, is a nonstimulant medication for attention-deficit/hyperactivity disorder (ADHD). This phase 3, double-blind, placebo-controlled, randomised-withdrawal study evaluated the long-term maintenance of GXR efficacy in children/adolescents with ADHD. Methods Children/adolescents (6–17 years) with ADHD received open-label GXR (1–7 mg/day). After 13 weeks, responders were randomised to GXR or placebo in the 26-week, double-blind, randomised-withdrawal phase (RWP). The primary endpoint was the percentage of treatment failure (≥50% increase in ADHD Rating Scale version IV total score and ≥2-point increase …

Malemedicine.medical_specialtyAdolescentPlacebo03 medical and health sciences0302 clinical medicineDouble-Blind MethodRating scaleInternal medicineOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineClinical endpointAdrenergic alpha-2 Receptor AgonistsHumansTreatment FailureGuanfacine HydrochloridePsychiatryTrial registrationChildTime to treatment failure030227 psychiatryGuanfacinePsychiatry and Mental healthAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsPediatrics Perinatology and Child HealthFemaleExtended releasePsychology030217 neurology & neurosurgeryEfficacy StudyJournal of child psychology and psychiatry, and allied disciplines
researchProduct

Insufficient control of heart rate in stable coronary artery disease patients in Latvia

2014

Background and objective:\ud Heart rate (HR) ≥70 beats per minute (bpm) increases cardiovascular risk in coronary artery disease (CAD) patients. The objective of the analysis is to characterize HR as well as other clinical parameters in outpatients with stable CAD in Latvia.<p></p>\ud \ud Materials and methods:\ud CLARIFY is an ongoing international registry of outpatients with established CAD. Latvian data regarding 120 patients enrolled in CLARIFY and collected at baseline visit during 2009–2010 were analyzed.<p></p>\ud \ud Results:\ud The mean HR was 67.7 ± 9.5 and 66.9 ± 10.7 bpm when measured by pulse palpation and electrocardiography, respectively. HR &#8…

Malemedicine.medical_specialtyAdrenergic beta-AntagonistsHeart rateCoronary artery diseaseAngina PectorisNOCoronary artery diseaseElectrocardiographyInternal medicineHeart ratemedicineHumansRegistriesCarvedilolAgedMetoprololHeart FailureMedicine(all)lcsh:R5-920Framingham Risk ScoreCoronary artery disease; Heart rate; Outpatient; Medicine (all)business.industryMedicine (all)OutpatientMiddle Agedmedicine.diseaseLatviaNebivololTreatment OutcomeBisoprololHeart failureAutomotive EngineeringCardiologycardiovascular systemFemalelcsh:Medicine (General)businessHeart rate; Coronary artery disease; Outpatienthuman activitiesmedicine.drugcirculatory and respiratory physiologyMedicina
researchProduct

Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study

2009

Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the condition, and to provide a framework for researchers to assess new risk markers.We assessed 4764 participants in the Framingham Heart Study from 8044 examinations (55% women, 45-95 years of age) undertaken between June, 1968, and September, 1987. Thereafter, participants were monitored for the first event of atrial fibrillation for a maximum of 10 years. Multivariable Cox regression identified clinical risk factors associated with development of atrial fibrillation in 10 years. Secondary analyses incorporated routine e…

Malemedicine.medical_specialtyAgingArticleSex FactorsFramingham Heart StudyRisk FactorsPredictive Value of TestsEpidemiologyAtrial FibrillationMedicineHumansLongitudinal StudiesRisk factorAgedProportional Hazards ModelsUltrasonographyAged 80 and overFramingham Risk ScoreHeart Murmursbusiness.industryCommunity ParticipationAbsolute risk reductionAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart failureHypertensionEmergency medicinePhysical therapyFemalebusinessCohort study
researchProduct

Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The “Bayes' Syndrome-HF” study

2018

Advanced interatrial block (IAB) is characterized by a prolonged (≥120 ms) and bimodal P wave in the inferior leads. The association between advanced IAB and atrial fibrillation (AF) is known as “Bayes' Syndrome”, and there is scarce information about it in heart failure (HF). We examined the prevalence of IAB and whether advanced IAB could predict new-onset AF and/or stroke in HF patients. Methods and results: The prospective observational “Bayes' Syndrome-HF” study included consecutive outpatients with chronic HF. The primary endpoints were new-onset AF, ischemic stroke, and the composite of both. A secondary endpoint included all-cause death alone or in combination with the primary endpo…

Malemedicine.medical_specialtyAll-cause deathEnfermedad cardiovascularAdvanced interatrial blockNew-onset atrial fibrillationHeart failure030204 cardiovascular system & hematologyFibrilación auricularBrain IschemiaElectrocardiography03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineAtrial FibrillationmedicineClinical endpointHumansInteratrial BlockSinus rhythmProspective Studies030212 general & internal medicineStrokeAgedSistema cardiovascularAged 80 and overHeart FailureProportional hazards modelbusiness.industryAtrial fibrillationInteratrial BlockSyndromeMiddle Agedmedicine.diseaseStrokeHeart failureCardiologyFemaleCardiopatía coronariaObservational studyInfarto de miocardioCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4

2010

Objective The objective was to assess the role of office and ambulatory blood pressure (BP) on the development of end-stage renal disease (ESRD) in nondiabetic chronic renal failure. Design and method Seventy-nine patients [mean age 57 (standard deviation 11) years, 47 men, BMI 28 (4), office BP 151 (25)/92 (14) mmHg, estimated glomerular filtration rate 28 (14) ml/min per 1.73 m3] were included. The causes of renal disease were nephrosclerosis (n = 33), glomerulonephritis (n = 19), interstitial (n = 12) and others (n = 15). The average follow-up was 44 months (range 9-72 months). The primary outcome was a composite of death, from any cause, or the development of ESRD that require initiatio…

Malemedicine.medical_specialtyAmbulatory blood pressurePhysiologymedicine.medical_treatmentRenal functionBlood Pressureurologic and male genital diseasesEnd stage renal diseaseInternal medicineInternal MedicinemedicineHumansRenal replacement therapyAgedbusiness.industryProportional hazards modelBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseCircadian RhythmSurgeryBlood pressureAmbulatoryDisease ProgressionCardiologyKidney Failure ChronicFemaleCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of Hypertension
researchProduct

A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dial…

2015

Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially Erythropoiesis Stimulating Agents (ESA) have become the treatment of choice for that anemia. However, it is very complicated to find an adequate treatment for every patient in each particular situation since dosage guidelines are based on average behaviors, and thus, they do not take into account the particular response to those drugs by different patients, although that response may vary enormously from one patient to another and even for the same patient in different stages of the anemia. This work proposes an advance with respec…

Malemedicine.medical_specialtyAnemiamedicine.medical_treatmentPopulationHealth InformaticsIron supplementMachine learningcomputer.software_genreModels BiologicalEnd stage renal diseaseCohort StudiesMachine LearningRenal DialysismedicineHumansIntensive care medicineeducationDialysiseducation.field_of_studybusiness.industryAnemiamedicine.diseaseAnemia managementComputer Science ApplicationsLarge cohortKidney Failure ChronicFemaleArtificial intelligencebusinesscomputerKidney diseaseComputers in Biology and Medicine
researchProduct